- Evelyn Stevenson joins as Director of Product Administration, Ravi Girdhar as Director of Gross sales within the EMEA area, and Denise Emsden as Vice-President of Individuals and Organizational Growth
- Key appointments kind a part of broader ongoing recruitment plans to assist expanded operations and product improvement
Sphere Fluidics, an organization creating single cell evaluation methods underpinned by its patented picodroplet expertise, introduced as we speak that it has appointed three new hires to its business crew. Evelyn Stevenson and Ravi Girdhar be part of as Director of Product Administration and Director of Gross sales (EMEA), respectively, alongside Denise Emsden as Vice-President of Individuals and Organizational Growth. Following the closure of a £26 million GBP (c. $36 million USD) funding spherical in 20211, the appointments assist the Firm’s subsequent stage of improvement to broaden product analysis and improvement, worldwide operations and gross sales in key international markets.
Evelyn Stevenson, BSc, is a world business chief with over 20 years’ expertise inside the life sciences market from firms corresponding to Azenta Life Sciences, Lonza and Thermo Fisher Scientific. Evelyn has intensive expertise in enterprise improvement and managing strategic relationships (each inside and exterior) to make sure product portfolio methods are extremely aligned to present and future enterprise wants. Evelyn commented, “We have now a improbable alternative to broaden our expertise into new markets, have a really thrilling product pipeline and an awesome crew behind us”.
Ravi Girdhar, MChem, joins Sphere Fluidics as Director of Gross sales, EMEA. Over the previous decade, Ravi has held varied business positions inside GE Healthcare, Thermo Fisher Scientific and most just lately at Gyros Protein Applied sciences. Ravi acknowledged, “It’s an thrilling time to hitch the Sphere Fluidics household because it has change into a key rising participant within the single cell evaluation analysis utilizing its patented picodroplet expertise. I’m thrilled to be part of the Firm’s business growth plans because it continues its ongoing success with an revolutionary product portfolio and pipeline to assist speed up biopharmaceutical discovery”.
Denise Emsden, FCIPD NEBOSH, joins Sphere Fluidics as VP of Individuals and Organizational Growth. Denise is an completed Human Sources skilled with vital business acumen. Expertise of working inside various industries, together with life sciences (Abcam, Mundipharma), FMCG (Sainsburys) and Elite Sports activities (Juddmonte), ensures a balanced, pragmatic and thought of method is taken. Denise famous, “I’m very excited to hitch Sphere Fluidics at this level of their evolution. The chance to assist the organisation to draw, develop, interact, and retain the very best expertise to realize our strategic targets is extremely compelling for me”.
Dr Frank F Craig, CEO, Sphere Fluidics, mentioned “This growth is funded by our current $40 million fund increase which can assist drive the enterprise to larger success. We have now additionally employed some wonderful technical and operations workers and are presently additionally hiring a number of different senior managers to assist develop the business and monetary groups. These hires, plus a plan for a brand new facility, demonstrates this pivotal time for the enterprise”.